Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Remacemide hydrochloride

Remacemide hydrochloride

Remacemide hydrochloride structure

Remacemide hydrochloride 

structure
  • CAS No:

    111686-79-4

  • Formula:

    C17H20N2O.ClH

  • Chemical Name:

    Remacemide hydrochloride

  • Synonyms:

    Acetamide,2-amino-N-(1-methyl-1,2-diphenylethyl)-,hydrochloride (1:1);Acetamide,2-amino-N-(1-methyl-1,2-diphenylethyl)-,monohydrochloride,(±)-;Acetamide,2-amino-N-(1-methyl-1,2-diphenylethyl)-,monohydrochloride;FPL 12924AA;PR 934-423A;Remacemide hydrochloride;2-Amino-N-(1,2-diphenylpropan-2-yl)acetamide hydrochloride;118754-06-6

Remacemide hydrochloride Basic Attributes

304.81

304.13400

DTXSID9045683

2924299090

Characteristics

55.1

4.11260

white to beige

253-254°

466.4ºC at 760mmHg

235.9ºC

H2O: >10mg/mL

Desiccate at RT

7.09E-09mmHg at 25°C

LD50 (calculated as base) in rats (mg/kg): ~50 i.v., ~900 orally (Muir, Palmer)

Safety Information

UN 3077 9 / PGIII

3

22-41-50/53

26-39-45-60-61

AB4349500

Xn,N

P273-P280-P305 + P351 + P338

H302-H318-H400

|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P273, P280, P301+P312, P305+P351+P338, P310, P330, P391, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)|Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)

2-amino-N-(1-methyl-1,2-diphenylethyl)acetamide

Remacemide hydrochloride Use and Manufacturing

Anticonvulsant (neuroprotective).Non-competitive NMDA receptor antagonist; blocks ion channel and allosteric modulatory site (IC 50 = 8-68 mM). Anticonvulsant in vivo and metabolizes to a more potent desglycine analog. Weakly blocks voltage-dependent Na + channels (IC 50 = 161 mM).

Computed Properties

Molecular Weight:304.8
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:5
Exact Mass:304.1342410
Monoisotopic Mass:304.1342410
Topological Polar Surface Area:55.1
Heavy Atom Count:21
Complexity:306
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.